Lukas Kern
Pneumologie und Schlafmedizin · Dept. I
Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.
Lichtensteiger C, Koblischke M, Berner F, Jochum A, Sinnberg T, Balciunaite B, Purde M, Walter V, Abdou M, Hofmeister K, Kohler P, Vernazza P, Albrich W, Kahlert C, Zoufaly A, Traugott M, Kern L, Pietsch U, Kleger G, Filipovic M, Kneilling M, Cozzio A, Pop O, Bomze D, Bergthaler A, Hasan A, Aberle J, Flatz L. Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients. J Autoimmun 2023; 140:103118.
10.10.2023Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.
10.10.2023J Autoimmun 2023; 140:103118
Lichtensteiger Christa, Koblischke Maximilian, Berner Fiamma, Jochum Ann-Kristin, Sinnberg Tobias, Balciunaite Beatrice, Purde Mette-Triin, Walter Vincent, Abdou Marie-Therese, Hofmeister Kathrin, Kohler Philipp, Vernazza Pietro L, Albrich Werner, Kahlert Christian, Zoufaly Alexander, Traugott Marianna T, Kern Lukas, Pietsch Urs, Kleger Gian-Reto, Filipovic Miodrag, Kneilling Manfred, Cozzio Antonio, Pop Oltin, Bomze David, Bergthaler Andreas, Hasan Ali, Aberle Judith, Flatz Lukas
Characteristics of Severe Asthma Patients and Predictors of Asthma Control in the Swiss Severe Asthma Registry.
Jaun F, Tröster L, Giezendanne S, Bridevaux P, Charbonnier F, Clarenbach C, Gianella P, Jochmann A, Kern L, Miedinger D, Nikolay P, Rothe T, Steurer-Stey C, von Garnier C, Leuppi J. Characteristics of Severe Asthma Patients and Predictors of Asthma Control in the Swiss Severe Asthma Registry. Respiration 2023; 102:863-878.
28.09.2023Characteristics of Severe Asthma Patients and Predictors of Asthma Control in the Swiss Severe Asthma Registry.
28.09.2023Respiration 2023; 102:863-878
Jaun Fabienne, Tröster Lydia Marie, Giezendanne Stéphanie, Bridevaux Pierre-Olivier, Charbonnier Florian, Clarenbach Christian F, Gianella Pietro, Jochmann Anja, Kern Lukas, Miedinger David, Nikolay Pavlov, Rothe Thomas, Steurer-Stey Claudia, von Garnier Christophe, Leuppi Joerg Daniel
[COPD - An Underestimated Disease].
Leuppi J, Bridevaux P, Charbonnier F, Clarenbach C, Duchna H, Fellrath J, Gianella P, Jochmann A, Kern L, Nikolay P, Rothe T, Steurer-Stey C, von Garnier C. [COPD - An Underestimated Disease]. Praxis (Bern 1994) 2023; 112:403-412.
01.06.2023[COPD - An Underestimated Disease].
01.06.2023Praxis (Bern 1994) 2023; 112:403-412
Leuppi Joerg Daniel, Bridevaux Pierre-Olivier, Charbonnier Florian, Clarenbach Christian F, Duchna Hans-Werner, Fellrath Jean-Marc, Gianella Pietro, Jochmann Anja, Kern Lukas, Nikolay Pavlov, Rothe Thomas, Steurer-Stey Claudia, von Garnier Christophe
Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19.
Sinnberg T, Lichtensteiger C, Ali O, Pop O, Risch L, Brugger S, Velic A, Bomze D, Kohler P, Vernazza P, Albrich W, Kahlert C, Abdou M, Wyss N, Hofmeister K, Niessner H, Zinner C, Gilardi M, Tzankov A, Röcken M, Dulovic A, Shambat S, Ruetalo N, Buehler P, Scheier T, Jochum W, Kern L, Henz S, Schneider T, Kuster G, Lampart M, Siegemund M, Bingisser R, Schindler M, Schneiderhan-Marra N, Kalbacher H, McCoy K, Spengler W, Brutsche M, Macek B, Twerenbold R, Penninger J, Matter M, Flatz L, Jochum A. Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19. Am J Respir Crit Care Med 2023; 207:38-49.
01.01.2023Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19.
01.01.2023Am J Respir Crit Care Med 2023; 207:38-49
Sinnberg Tobias, Lichtensteiger Christa, Ali Omar Hasan, Pop Oltin T, Risch Lorenz, Brugger Silvio D, Velic Ana, Bomze David, Kohler Philipp, Vernazza Pietro, Albrich Werner, Kahlert Christian, Abdou Marie-Therese, Wyss Nina, Hofmeister Kathrin, Niessner Heike, Zinner Carl, Gilardi Mara, Tzankov Alexandar, Röcken Martin, Dulovic Alex, Shambat Srikanth Mairpady, Ruetalo Natalia, Buehler Philipp K, Scheier Thomas C, Jochum Wolfram, Kern Lukas, Henz Samuel, Schneider Tino, Kuster Gabriela M, Lampart Maurin, Siegemund Martin, Bingisser Roland, Schindler Michael, Schneiderhan-Marra Nicole, Kalbacher Hubert, McCoy Kathy D, Spengler Werner, Brutsche Martin H, Macek Boris, Twerenbold Raphael, Penninger Josef M, Matter Matthias S, Flatz Lukas, Jochum Ann-Kristin
The clinical features of asthma exacerbations in early-onset and eosinophilic late-onset asthma may differ significantly.
Rothe T, von Garnier C, Bridevaux P, Charbonnier F, Clarenbach C, Gianella P, Jochmann A, Kern L, Nikolay P, Steurer-Stey C, Leuppi J. The clinical features of asthma exacerbations in early-onset and eosinophilic late-onset asthma may differ significantly. Respir Med 2022; 206:107067.
09.12.2022The clinical features of asthma exacerbations in early-onset and eosinophilic late-onset asthma may differ significantly.
09.12.2022Respir Med 2022; 206:107067
Rothe Thomas, von Garnier Christophe, Bridevaux Pierre-Olivier, Charbonnier Florian, Clarenbach Christian, Gianella Pietro, Jochmann Anja, Kern Lukas, Nikolay Pavlov, Steurer-Stey Claudia, Leuppi Joerg D
Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series.
Rüfenacht S, Gantenbein P, Boggian K, Flury D, Kern L, Dollenmaier G, Kohler P, Albrich W. Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series. Infection 2022; 50:783-790.
15.04.2022Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series.
15.04.2022Infection 2022; 50:783-790
Rüfenacht Susanne, Gantenbein Pascal, Boggian Katia, Flury Domenica, Kern Lukas, Dollenmaier Günter, Kohler Philipp, Albrich Werner
Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
Hasan Ali O, Bomze D, Risch L, Brugger S, Paprotny M, Weber M, Thiel S, Kern L, Albrich W, Kohler P, Kahlert C, Vernazza P, Bühler P, Schüpbach R, Gómez-Mejia A, Popa A, Bergthaler A, Penninger J, Flatz L. Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies. Clin Infect Dis 2021; 73:1746.
02.11.2021Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
02.11.2021Clin Infect Dis 2021; 73:1746
Hasan Ali Omar, Bomze David, Risch Lorenz, Brugger Silvio D, Paprotny Matthias, Weber Myriam, Thiel Sarah, Kern Lukas, Albrich Werner, Kohler Philipp, Kahlert Christian, Vernazza Pietro, Bühler Philipp K, Schüpbach Reto A, Gómez-Mejia Alejandro, Popa Alexandra M, Bergthaler Andreas, Penninger Josef M, Flatz Lukas
Bronchodilator Response in Patients with COPD, Asthma-COPD-Overlap (ACO) and Asthma, Evaluated by Plethysmographic and Spirometric z-Score Target Parameters
Kraemer R, Smith H, Gardin F, Barandun J, Minder S, Kern L, Brutsche M. Bronchodilator Response in Patients with COPD, Asthma-COPD-Overlap (ACO) and Asthma, Evaluated by Plethysmographic and Spirometric z-Score Target Parameters. Int J Chron Obstruct Pulmon Dis 2021; 16:2487-2500.
01.09.2021Bronchodilator Response in Patients with COPD, Asthma-COPD-Overlap (ACO) and Asthma, Evaluated by Plethysmographic and Spirometric z-Score Target Parameters
01.09.2021Int J Chron Obstruct Pulmon Dis 2021; 16:2487-2500
Kraemer Richard, Smith Hans-Jürgen, Gardin Fabian, Barandun Jürg, Minder Stefan, Kern Lukas, Brutsche Martin
Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies
Hasan Ali O, Penninger J, Bergthaler A, Popa A, Gómez-Mejia A, Schüpbach R, Bühler P, Vernazza P, Kahlert C, Kohler P, Albrich W, Kern L, Thiel S, Weber M, Paprotny M, Brugger S, Risch L, Bomze D, Flatz L. Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies. Clin Infect Dis 2021; 73:e2869-e2874.
02.01.2021Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies
02.01.2021Clin Infect Dis 2021; 73:e2869-e2874
Hasan Ali Omar, Penninger Josef M, Bergthaler Andreas, Popa Alexandra M, Gómez-Mejia Alejandro, Schüpbach Reto A, Bühler Philipp K, Vernazza Pietro, Kahlert Christian, Kohler Philipp, Albrich Werner, Kern Lukas, Thiel Sarah, Weber Myriam, Paprotny Matthias, Brugger Silvio D, Risch Lorenz, Bomze David, Flatz Lukas
Multimodel inference applied to oxygen recovery kinetics after 6-min walk tests in patients with chronic obstructive pulmonary disease
Baty F, Ritz C, Jensen S, Kern L, Tamm M, Brutsche M. Multimodel inference applied to oxygen recovery kinetics after 6-min walk tests in patients with chronic obstructive pulmonary disease. PloS one 2017; 12:e0187548.
08.11.2017Multimodel inference applied to oxygen recovery kinetics after 6-min walk tests in patients with chronic obstructive pulmonary disease
08.11.2017PloS one 2017; 12:e0187548
Baty Florent, Ritz Christian, Jensen Signe Marie, Kern Lukas, Tamm Michael, Brutsche Martin
Oxygen Uptake Recovery Kinetics after the 6-Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease
Baty F, van Gestel A, Kern L, Brutsche M. Oxygen Uptake Recovery Kinetics after the 6-Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease. Respiration 2016; 92:371-379.
09.11.2016Oxygen Uptake Recovery Kinetics after the 6-Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease
09.11.2016Respiration 2016; 92:371-379
Baty Florent, van Gestel Arnoldus J R, Kern Lukas, Brutsche Martin
Oxygen kinetics during 6-minute walk tests in patients with cardiovascular and pulmonary disease
Kern L, Condrau S, Baty F, Wiegand J, van Gestel A, Azzola A, Tamm M, Brutsche M. Oxygen kinetics during 6-minute walk tests in patients with cardiovascular and pulmonary disease. BMC Pulm Med 2014; 14:167.
29.10.2014Oxygen kinetics during 6-minute walk tests in patients with cardiovascular and pulmonary disease
29.10.2014BMC Pulm Med 2014; 14:167
Kern Lukas, Condrau Sophie, Baty Florent, Wiegand Jan, van Gestel Arno Jr, Azzola Andrea, Tamm Michael, Brutsche Martin
Swiss national guideline for reimbursement of enzyme replacement therapy in late-onset Pompe disease
Hundsberger T, Rohrbach M, Kern L, Rösler K. Swiss national guideline for reimbursement of enzyme replacement therapy in late-onset Pompe disease. J Neurol 2013; 260:2279-2285.
08.06.2013Swiss national guideline for reimbursement of enzyme replacement therapy in late-onset Pompe disease
08.06.2013J Neurol 2013; 260:2279-2285
Hundsberger Thomas, Rohrbach Marianne, Kern Lukas, Rösler Kai M
Exploring the transcription factor activity in high-throughput gene expression data using RLQ analysis
Baty F, Rüdiger J, Miglino N, Kern L, Borger P, Brutsche M. Exploring the transcription factor activity in high-throughput gene expression data using RLQ analysis. BMC bioinformatics 2013; 14:178.
06.06.2013Exploring the transcription factor activity in high-throughput gene expression data using RLQ analysis
06.06.2013BMC bioinformatics 2013; 14:178
Baty Florent, Rüdiger Jochen, Miglino Nicola, Kern Lukas, Borger Peter, Brutsche Martin